sectors, including the pharmaceutical, biotechnology and medical device industries review provisions of the Privacy Rule relevant to health research, including those dealing with authorizations and accounting for disclosures of personal health information, de-identification of data, reviews preparatory to research, and others, and on reviewing them, may identify provisions that merit priority atte